Observations on the Efficacy and Safety of Dupilumab as an Anti-Itch Agent in Special Populations
Global Insights in Medicine and Nursing · 24.06.2026 · 2 (2) · 27-33
DOI: 10.65140/gimn202601.19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Insights in Medicine and Nursing, online erschienen am 24.06.2026. Verfasst von Yinchuan Zuo und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Dupilumab relieves inflammatory response and alleviates skin itch by blocking interleukin-4 (IL-4), interleukin-13 (IL- 13) in relevant signalling pathways. It also needs further research into efficacy and safety of dupilumab as a pruritus relieving agent in specific populations.
Objective
This study aimed to observe the efficacy and safety of dupilumab as a pruritus relief agent in specific populations.
Methods
Thirty-one patients with pruritus (28 systemic and 3 idiopathic) were treated with subcutaneous injections of dupilumab. Efficacy was assessed before treatment, at 4 weeks post-treatment, and at 8 weeks post-treatment.
Results
After 4 weeks of treatment, the effectiveness rate was 70.4%, and after 8 weeks of treatment, the effectiveness rate was 96.3%; compared with before treatment, the NRS scores of pruritus decreased after 4 weeks of treatment and 8 weeks of treatment significantly. The difference of NRS scores was statistically significant (F= 103.679, P
Zitieren
APA
Zuo, Y., Zhao, Z., Wu, J., Gong, L., Lin, B., Yao, Y., Wu, S., Wei, F., Shen, L., Li, C., & Song, C. (2026). Observations on the Efficacy and Safety of Dupilumab as an Anti-Itch Agent in Special Populations. Global Insights in Medicine and Nursing, 2(2), 27-33. https://doi.org/10.65140/gimn202601.19
Vancouver
Zuo Y, Zhao Z, Wu J, Gong L, Lin B, Yao Y, et al. Observations on the Efficacy and Safety of Dupilumab as an Anti-Itch Agent in Special Populations. Global Insights in Medicine and Nursing. 2026;2(2):27-33. doi:10.65140/gimn202601.19
BibTeX
@article{Zuo2026,
author = {Zuo, Yinchuan and Zhao, Zhenkai and Wu, Jintong and Gong, Lingling and Lin, Biwen and Yao, Yuxiang and Wu, Shurui and Wei, Fangfang and Shen, Lin and Li, Chengxin and Song, Cuihao},
title = {Observations on the Efficacy and Safety of Dupilumab as an Anti-Itch Agent in Special Populations},
journal = {Global Insights in Medicine and Nursing},
year = {2026},
volume = {2},
number = {2},
pages = {27--33},
doi = {10.65140/gimn202601.19}
}
EUVIMED